MSCs from Amniotic Membrane

MSCs from Amniotic Membrane for Diabetes (Type 1 & 2)

How Stem Plus applies MSCs from Amniotic Membrane within a personalised Diabetes (Type 1 & 2) protocol — in the EU, from €3,000–€8,000.

For Diabetes (Type 1 & 2), MSCs from Amniotic Membrane are selected for their specific regenerative profile and delivered under GMP conditions. The protocol combines cell type, dose and delivery route to match your individual assessment.

This is one of several cell options for Diabetes (Type 1 & 2). Compare them on the Diabetes (Type 1 & 2) overview, or see the MSCs from Amniotic Membrane page.

Educational information; investigational for several conditions. Outcomes vary.

European-grade cell therapy, without European prices.

GMP-certified regenerative medicine in the heart of the EU — from €3,000–8,000, a fraction of US or German pricing. Personalised protocols for international patients from 50+ countries.

Free medical review